Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
May
24
2025
 EC Announces Low- and High-Risk Countries under the EUDR Bergeson & Campbell, P.C.
May
23
2025
 The Trump Administration Announces Trade Agreement With China K&L Gates LLP
May
23
2025
 Orange Book Listings: Republican Led FTC Picks Up Where Democrat Led FTC Left Off Polsinelli PC
May
23
2025
 McDermott+ Check-Up: May 23, 2025 McDermott Will & Emery
May
23
2025
 Bipartisan Bill Would Expand Biofuels and Biobased Manufacturing Innovation Bergeson & Campbell, P.C.
May
23
2025
 U.S. District Judge Upholds Federal Preemption Over Minnesota State Drug Testing Law Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
May
22
2025
 This Week in 340B: May 13 – 19, 2025 McDermott Will & Emery
May
22
2025
 FDA Warning Letter Takes Issue with Designation of Substance as Dietary Ingredient Keller and Heckman LLP
May
22
2025
 Nebraska to Restrict SNAP Soda and Energy Drink Purchases Keller and Heckman LLP
May
21
2025
 Considerations for Life Sciences Employers When Planning Reductions in Force Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
May
21
2025
 The Trump Administration Announces Price Targets as It Takes a Second Swing at “Most Favored Nation” Drug Pricing Model Polsinelli PC
May
21
2025
 FDA Advances Post-Market Chemical Review Program Bergeson & Campbell, P.C.
May
21
2025
 Congress and the Feds — the Impact of Nonperformance Bergeson & Campbell, P.C.
May
21
2025
 Guarding Against the Unknown: M&A Due Diligence of AI Companies in Data-Sensitive Sectors Sheppard, Mullin, Richter & Hampton LLP
May
21
2025
 Maryland Delays Start of Paid Family and Medical Leave Program Epstein Becker & Green, P.C.
May
21
2025
 What Means Means for Mushrooms and Marijuana: How Might Trump’s Surgeon General Nominee Shift the Conversation for Cannabis and Psychedelics? Bradley Arant Boult Cummings LLP
May
21
2025
 New Mexico Legalizes Medical Use of Psilocybin Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
May
20
2025
 Food as Medicine: A Deep Dive Into Reimbursement McDermott Will & Emery
May
20
2025
 Was Rescheduling a Pipe Dream? DEA Questions Reliability of State-Run Programs and Impact on Transnational Crime Bradley Arant Boult Cummings LLP
May
19
2025
 There are Two Sides to Every Story — Eleventh Circuit Grapples With Discrimination Standard Foley & Lardner LLP
May
19
2025
 FDA and HHS Solicit Comments on Deregulation Keller and Heckman LLP
May
19
2025
 FDA Announces Plans for Post-Market Review of Chemicals in Food Keller and Heckman LLP
May
16
2025
 McDermott+ Check-Up: May 16, 2025 McDermott Will & Emery
May
16
2025
 Reflections on the FDLI 2025 Annual Conference – Differing Tones, Shared Goals Sheppard, Mullin, Richter & Hampton LLP
May
15
2025
 “AI Policy Roadmap” Released by AdvaMed to Guide Regulators Foley & Lardner LLP
May
15
2025
 Focus, Fairness and Efficiency: DOJ Reveals Administration’s Plans for Enforcement of Corporate and White-Collar Crime Polsinelli PC
May
15
2025
 Trump Administration Announces New Executive Order to Promote Domestic Production of Biopharmaceuticals Polsinelli PC
May
15
2025
 New EO Targets Prescription Drug Costs – and Drug Manufacturers, Hospitals, and Health Centers McDermott Will & Emery
Displaying 1 - 28 of 12278
Subscribe to The 10 Latest Biological, Life Sciences, and Cleantech Law Articles
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters